Guided movement
XR-based motion capture supports a repeatable assessment sequence without relying on manual angle estimation.
KineTrax™ is developing an XR-based platform for structured measurement of cervical movement during clinician-governed assessment.
Guided cervical movement using XR-based motion sensing.
Measurements organised into a consistent digital assessment record.
Outputs reviewed and interpreted by the examining clinician.
KineTrax™ uses commercially available XR hardware and motion sensing to capture cervical movement through a structured assessment protocol.
The system is being developed to create a consistent measurement record that can be reviewed alongside the wider clinical assessment.
Initial development is focused on cervical movement measurement for clinical, occupational-health and independent medical assessment workflows.
XR-based motion capture supports a repeatable assessment sequence without relying on manual angle estimation.
Movement data are organised into a digital record designed for comparison across assessment time points.
All outputs are intended to be reviewed and interpreted by the examining clinician.
KineTrax™ is being developed on a research foundation in cervical kinematics and movement analysis.
Clinical and technical validation work is intended to establish measurement performance, repeatability, usability and workflow fit before broader commercial claims are made.
Specific publications to be added to the beta once the approved evidence list is confirmed.
Planned evidence areas include repeatability, usability and comparison with reference measurement approaches.
Diagnostic, treatment, predictive and claim-validation claims are outside the current public product description.
Kinematic Tracing Systems Ltd is developing KineTrax™ as a measurement platform for cervical movement assessment.
The company is currently focused on product development, validation, regulatory preparation and early clinical workflow evaluation.
Team profiles and approved partner references can be added once the public disclosure list is confirmed.
KTS is engaging with clinicians, research partners, independent medical assessment providers and occupational-health organisations as part of the development process.